Lung cancer (LC) is the leading cause of cancer-related death worldwide and miRNAs play
a key role in LC development. To better diagnose LC and to predict drug treatment …

Precision medicine was born with the development of new diagnostic techniques and
targeted drugs, yielding better outcomes in cancer care. With the evolution and increasing …

Importance The overall low survival rate of patients with lung cancer calls for improved
detection tools to enable better treatment options and improved patient outcomes …

Minimally invasive testing for early detection of lung cancer to improve patient survival is a
major unmet clinical need. This study aimed to develop and validate a serum multi …

Precision medicine has impacted the field of medical oncology by introducing personalized
therapies, improving all measurable outcomes. This field, in turn, has expanded to obtaining …

Simple Summary Blood-based cancer biomarkers are a minimally invasive means to
achieve improved assessment of risk and/or earlier detection of lung cancer. Using serum …

Lung cancer is one of the most common malignant tumors associated with cancer death;
however, the mechanisms involved in lung tumor development have not been completely …

Lung cancer, a leading cause of cancer-related mortality, has a low rate of early diagnosis
and a poor prognosis for advanced stages. Recent advances in further mastery of the …

Non-small cell lung cancer (NSCLC) comprises 85% of all lung cancers and is a malignant
condition resistant to advanced-stage treatment. Despite the advancement in detection and …

Background The development of biomarkers for the early detection of non‐small cell lung
cancer (NSCLC) is clinically important. We have developed miRNA biomarkers in sputum …